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INTRODUCTION
About ten years ago, I began looking for a research problem in the field of plant-microbe interactions. As the name implies, this is the study of how plants and microorganisms associate-either for
their mutual benefit or at the expense of one partner. An example is symbiotic nitrogen fixation
between leguminous plants and root-colonizing bacteria. Both benefit-the plant gains nitrogen in a
useful form and the bacteria gain nutrients and protection. A better understanding of a plant-microbe
interaction system could be used to benefit agriculture. For example, boosting nitrogen fixation
would mean less petroleum-derived nitrogen fertilizers. These interactive biological systems and
their applications were attractive tome. Frequent articles appeared in the prestigious science magazines, Science and Nature, describing new and fascinating problems in plant-microbe interactions,
including many that could be addressed at the molecular level. My colleagues in the Department of
Biology who were conducting research in this area encouraged me to join them. It was also relevant
to the mission of the Utah Agricultural Experiment Station which had been very supportive of my
work.
My background is in microbiology and biochemistry with emphasis on phenomena related to
cell membranes. All living cells use membranes to regulate which substances are allowed in and out
of their various compartments (Fig. 1).

Major Cell Membranes
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Fig. 1. Drawing of major membranes ofa typical cell.
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Like most cellular processes, those of plant-microbe interactions depend on the functions of
membranes. Included are membrane effects of toxic molecules produced by microbial pathogens
(Daly and Deverall, 1983). One of these toxins was syringomycin. It is produced by a tenacious
bacterial plant pathogen and was thought to be the major virulence factor in several diseases (DeVay
et aI., 1968). Because neither the details of how it worked or its chemical structure were known, I
decided to study this plant toxin and learn its characteristics and how it interacted with membranes.
As I describe below, however, we learned that syringomycin was not a major plant virulence factor.

SYRINGOMYCIN AND THE BACTERIA THAT PRODUCE IT
Syringomycin is produced by bacteria classified as Pseudomonas syringae pv. syringae (Gross,
1991). These bacteria are closely associated with a variety of plants and usually on the aerial surfaces.
Normally, P. syringae pv. syringae tries to survive without compromising its plant host. However,
when the host is physically damaged (e.g. by freezing) or diseased, certain opportunistic strains of P.
syringae pv. syringae invade the plant and contribute to its death. " Because syringomycin is produced
by certain opportunistic strains of P. syringae pv. syringae and appeared to be toxic, it was thought to be
a major virulence factor.
By the early 1980's, there was some evidence suggesting that syringomycin targeted membranes, particularly the plasma membrane. The plasma membrane surrounds the periphery of cells
(Fig. 1), and in plant cells, it lies just beneath a tough, outer shell of cell wall material. It was thought,
for example, that syringomycin preferentially binds to the plasma membrane of plant cells, based on
the reaction of rabbit antibodies directed against a preparation of syringomycin. The antibodies,
which presumably bound tightly to syringomycin, were in turn labeled with a fluorescent dye to
locate the toxin in infected plant tissues (Paynter and Alconero, 1979).

SYRINGOMYCIN'S POSSIBLE ROLE AS AN IRON CHELATOR
In 1982, two articles reported that a component of syringomycin was 8-N-hydroxyornithine
(Gross, 1982; Hemming et aI., 1982). All natural molecules possessing 8-N-hydroxyornithine functioned as iron chelators. Microbes produce iron chelators, which tightly bind iron to satisfy the microbes' nutritional requirement for this element. If syringomycin contained 8-N-hydroxyornithine, it
was probably an iron chelator, and its toxicity would involve iron binding on the host plant membranes. The notion was also consistent with the observation that syringomycin production by P.
syringae pv. syringae in cultures was stimulated when iron was added.
This discovery was serendipitous. At that time, my laboratory at Utah State University was
located in Widtsoe Hall adjacent to the laboratory of Dr. Thomas Emery who was an expert on iron
chelators. He was also the world's foremost expert on 8-N-hydroxyornithine which he discovered
when he was a graduate student. When I read that syringomycin w_as an d-N-hydroxyornithinecontaining iron chelator, I ran over to Emery's lab to show him the papers. Emery pondered them for
a moment and said, "I don't believe it." The reason was that 8-N-hydroxyornithine is not easy to
identify with the conventional chemical stain (an acidified ninhydrin stain) that was used by the
syringomycin researchers. 8-N-hydroxyornithine reacts quickly with this stain, but so eventually do
other related amino acids (diamino acids). (Only an expert could know this). Emery guessed that
diamino acids, not 8-N-hydroxyornithine, were present in syringomycin. He also explained that the
addition of iron would not stimulate syringomycin production if it was an iron chelator. Microorganisms produce iron chelators when they are starved for iron, not when iron is abundant.
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We reinvestigated the occurrence of 8-N-hydroxyornithine in syringomycin and within a
month learned that syringomycin was composed of several amino acids, including 2,4-diaminobutyric
acid that the earlier workers misidentified as 8-N-hydroxyornithine (Bachmann and Takemoto, 1989)
(Fig. 2). In addition, we found no evidence for iron binding to syringomycin. Emery was correct.
Syringomycin is not an iron chelator.

o-N-hydroxyornithine
NH2
I

HO-NH-C~ -CH 2 -CH 2 -CH-COOH
2,4-diaminobutyric acid

Fig. 2. The st17lctures of two chemically-related amino acids. 8-N-hydroxyornithine was reported to occur in synngomycin, but
it was actually 2,4-diaminobutync acid.

CHEMICAL STRUCTURE OF SYRINGOMYCIN
J

The iron chelator research initiated the effort to learn syringomycin's chemical structure.
There were several reasons why my students and I decided to do this, but two warrant mentioning.
First, elucidating the structure could provide clues about its mechanism of action, which was our
main interest. This had been demonstrated in our work concerning 8-N-hydroxyornithine. Second,
only when we knew the structure could we be sure that we ~ere working with a pure molecule. If
preparations were not pure, events elicited by the impurities could be mistakenly attributed to the
molecule.
We estimated that it would require no more than one year to determine the entire structure of
syringomycin. It required four. One reason was that we were not "real" chemists; another was the
complexity of the task. As biologists, we struggled with many technical problems that experienced
chemists would have overcome quickly. Later, we collaborated with a group of Italian chemists, led
by Professor Alessandro Ballio, who were also attempting to determine syringomycin's structure.
(Both groups had reached the same point. As biologists, we were pleased that we had made as much
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progress as these chemists). Deciphering syringomycin's structure was a difficult challenge that
involved the identification of unusual and new amino acids. Nevertheless, we succeeded (Segre et
al., 1989). Syringomycin's structure is shown in Fig. 3.

Syringomycin
OH

OH
I

I

CI
I

HP-(CHtn-CH-CHiCO-Ser-Ser-Dab-Dab-Arg-Phe-Dhb-Asp-Thr

I

o

I

CO

n == 8, syringomycin-E (predominant form)
n == 6, syringomycin-A 1
n == 10, syringomycin-G

Fig. 3. The structure ofsyringomycin - its major and minor forms.

The E-form is the most abundant and active of the structural forms. Syringomycin-E is a
lipopeptide, a combination of a lipid (actually a fatty acid) and a peptide. The peptide portion contains amino acids arranged in a cycle. Certain of the amino acids are rare. For example,
chlorothreonine had not been previously reported, and 2,4-diaminobutyric acid and p-hydroxyaspartic
acid do not commonly occur in nature.
The structure did indicate how syringomycin acts. As hypothesized, syringomycin probably
interacted with membranes. It is an amphipathic molecule, with a water-attracting (hydrophilic)
domain as well as a water-repelling (hydrophobic) domain. Membranes composed of proteins and
lipids are arranged such that a hydrophobic layer is between two hydrophilic layers, an arrangement
which amphipathic molecules-like syringomycin-tend to interact with very strongly and specifically.
Soon after we published the structure of syringomycin-E, other reports described the structures of similar molecules produced by strains of P. synngae pv. synngae isolated from different plants.
For example, syringotoxin was found in strains on citrus trees (Ballio et al., 1990), and syringostatin
was recovered from a strain on lilac (Isogai et al., 1990). They have very similar chemical structures,
4

and appear to have similar roles in nature. Together, syringomycin, syringotoxin, and syringostatin
are now called the "syringomycins" or the syringomycin family of lipopeptides (Takemoto, 1992). In
the remainder of this essay, I will often refer to these molecules as the syringomycins.

THE SYRINGOMYCINS TARGET THE PLASMA MEMBRANES OF YEASTS
Researchers often used fungi to identify and study the syringomycins which was unusual
because the syringomycins were thought to be plant toxins. Fungi such as the yeasts were very
sensitive to the syringomycins, and they were used to assay for their presence. We decided to exploit
this sensitivity of fungi to study the syringomycins' mechanism of action. We studied yeasts such as
the common baker's yeast, Saccharomyces cerevisiae. For molecular biology and biochemical studies,
yeasts grow more rapidly and are more easily manipulated in the laboratory than plants. This accelerated research (but did not necessarily mean that the results were easier to interpret). We felt that
yeasts and plants were so similar that the syringomycins' actions on yeast would also apply to their
effects on plants.
We learned that syringomycin-E does indeed target the plasma membrane of yeasts
(Takemoto, 1992). These effects are summarized in Fig.4.

Fig. 4. TIze mojoreffects ofsyringomycin-E on the plosmo membrones ofyeost.

Syringomycin-E dramatically disturbs certain functions of the plasma membrane. For example, it stimulates the movements of calcium, potassium and hydrogen ions across the membrane.
The resulting distribution of positive and negative ions alters the membrane potential. The precise
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mechanisms of these changes are not known, but it appears that syringomycin binds to a component
in the plasma membrane. It also appears that syringomycin alters one or more proteins which function in transporting these ions across the membrane. One such alteration involves the attachment of
phosphates-protein phosphorylation which is catalyzed by enzymes called protein kinases. In
yeasts, an ATPase enzyme in the plasma membrane transports hydrogen ions. We demonstrated that
this enzyme is phosphorylated by a protein kinase, and that syringomycin markedly stimulates the
process (Bidwai and Takemoto, 1987; Suzuki et aI., 1992). All of these effects occur at syringomycin
concentrations that also inhibit the growth of yeasts, which means that these effects on the plasma
membrane reflect processes related to cell death.
Are plant plasma membranes also targeted by the syringomycins? This question is not easy to
answer. The syringomycins were initially thought to be toxins acting on plant plasma membranes, but
the toxicity of the syringomycins may vary with the purity of syringomycin preparations and the
amounts used. Some of the effects on plants and membranes were probably due to impurities. For
example, we now question the observations based on antibodies described above in which
syringomycin preparations used to prepare the antibodies were probably not pure. Excessive
amounts of syringomycin were probably used in other plant studies. Only very small amounts (e.g.,
less than 1 ug per ml) are required to affect yeasts. There are no observable effects when these same
amounts are added to plant cells or their plasma membranes. However, the use of higher levels (e.g.
2S ug per ml) results in effects similar to those seen with yeast, e.g. it stimulates protein phosphorylation of plant plasma membrane proteins (Bidwai and Takemoto, 1987). Thus, even though plant
plasma membranes do respond to the syringomycins, the large amounts that are-tequired indicate that
they may not be major plant virulence factors.

THE SYRINGOMYCINS ARE PRIMARILY ANTIFUNGAL AGENTS
The syringomycins can kill fungi, and do so at very low concentrations. They can kill a broad
range of well-known fungi including the yeasts and are "antifungal agents." Is this their main role in
nature? Are their roles as plant toxins secondary? It now appears that the syringomycins are primarily
antifungal agents based on evidence that I cite below.

YEAST MOLECULAR BIOLOGY AND THE IMPORTANCE OF ERGOSTEROL
My research group is now isolating and characterizing genes that encode proteins required for
inhibition by syringomycin-E (Takemoto et aI., 1991). The main goal of this work is to identify the
cellular events that occur when syringomycin-E kills yeasts. These events are either catalyzed by
proteins or depend on cell components that are synthesized by proteins. The initial step towards
isolating these genes involves the creation of yeast mutants resistant to syringomycin-E; this resistance would be due to defects caused by gene mutations, each of whi.ch disables a normal cell function. A function that confers resistance when defective must be involved in the yeast's response to
syringomycin-E. The next step involves the insertion of small DNA molecules (called plasmids)
containing non-mutated, normal yeast genes into the mutants. Following this genetic transformation,.
we then look for transformed mutants that have regained their sensitivity to syringomycin-E. Sensitive mutants that can express the normal version of a mutated gene are said to have undergone genetic complementation. The genes are then isolated (or cloned) by recovering the plasmids. After a
gene is excised from a plasmid, it can be chemically analyzed.
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Using this strategy, we cloned genes that encode proteins involved in the syringomycin-E
response. One of these genes, SYRl , is important when considering the role of the syringomycins as
antifungal agents. We determined the sequence of the nucleotides in SYRI and deduced the amino
acid sequence of the protein it encodes. A computer database of all known protein sequences was
searched recently, and we were astonished to tind another protein that matched the SYRl-encoded
protein. The sequence of this protein appeared in the literature just a few weeks earlier. It was
encoded by a gene named ERG3, and was identified as sterol C-S desaturase, a yeast enzyme which
synthesizes a fatty lipid called ergosterol (Fig. 5). Thus, the SYRI gene nucleotide sequence yielded
immediate and precise information about its function: SYRI allows the yeast to make ergosterol,
which is necessary for syringomycin-E to kill it.
Ergosterol synthesis explained why the mutants resisted syringomycin-E. As expected, the
levels of ergosterol in the mutants were dramatically reduced, and so was the amount of
syringomycin-E that was bound to the mutant cells. In other words, the mutants bound less
syringomycin-E than normal yeast, an indication that ergosterol is needed for syringomycin-E to bind
to the plasma membrane.

ergosterol
HO

cholesterol
HO

Fig. 5. The stroctures offungal ergosterol and its animal cell counterpatt, cholesterol.
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The requirement for ergosterol indicates that syringomycin-E is an antifungal agent. Ergosterol is found only in the fungi, and it is especially abundant in the yeasts. One of its structural
analogues is cholesterol (Fig. 5), which is found mainly in animal cells. Plants possess other kinds of
sterol lipids. Ergosterol is located exclusively in the plasma membranes of fungi, which could account for syringomycin-E's specific action on this membrane.

A NEW BACTERIAL FUNGAL ANTAGONIST
The syringomycins' antifungal properties are also suggested from recent microbiological
studies. Dr. Fatusa Adetuyi (a Nigerian microbiologist visiting my laboratory this year) isolated
several new strains of P. syringae pv. syringae from wheat kernels on a farm in Benson, Utah. One
isolate, which Dr. Adetuyi called strain M 1, was an effective antagonistic of fungi that produced
substantial levels of syringomycin-E. Strain Ml was not pathogenic to wheat or to other plants tested.
Thus, P. syringae pv .. syringae is not always a plant pathogen, nor is syringomycin production correlated
with plant disease. Dr. Adetuyi is isolating and studying more strains of P. syringae pv. syringae to
clarify the relationships between syringomycin production, fungal antagonism, and plant pathogenesis. The early observations with strain Ml, however, indicate that the syringomycins are mainly
antifungal agents.
If the syringomycins are not major plant virulence factors, then why are some strains of Pseudomonas syringae pv. syringae opportunistic pathogens? At present, we can only speculate. Several
research groups have found genes in bacterial plant pathogens which are called hrp genes (for hypersensitivity and pathogenicity genes) (Willis et al. 1991). These genes also occur in certain P. syringae
pv. syringae strains. Hrp genes are associated with pathogenicity, and also appear to determine which
plants will be susceptible to particular bacterial pathogens. In contrast, Dr. Dennis Gross of Washington State University has identified genes necessary for the synthesis of syringomycin. Comparisons
of the two sets of genes show that the syringomycin synthetic genes are not hrp genes. Thus, P.
syringae pv. syringae's pathogenicity is probably conferred by the hrp genes, and not the syringomycin
genes. Further insight is hampered by our ignorance of the proteins encoded by the hrp genes. This
is a major focus of research in plant-microbe interactions.

SYRINGOMYCINS FOR BIOCONTROL OF PLANT PATHOGENIC FUNGI
If the syringomycins are antifungal agents, what advantage does this confer? As stated above,
these bacteria normally exist on plant aerial surfaces and feed on the scarce nutrients provided by the
plant. P. syringae pv. syringae must compete with other microorganisms, such as fungi, for space and
food. They are successful competitors, and it is widely believed that the success of these bacteria is
partly due to the production and use of antibiotics for eliminating other microbes (Blakeman, 1985).
Thus, the syringomycins appear to be antibiotic weapons used by P. syringae pv. syring(le to compete
against its fungal enemies.
It might be possible to exploit the syringomycins to fight plant fungal diseases. Fungal diseases account for greater than 90% of the plant diseases worldwide. Synthetic fungicides have been
use to combat these diseases, but there is an increased emphasis on the identification and development of biocontrol methods, natural biological methods of disease control with minimal impacts on
the environment or human health.

My colleagues and I are now examining the potential of using the syringomycins in the
8

biocontrol of dwarf bunt of winter wheat, a fungal disease. In the USA, this disease is confined to the
Northwest including Northern Utah (Hoffman, 1982). Dwarf bunt has resulted in export restrictions,
particularly to China, to limit spread of the disease. As a consequence, Northwest wheat farmers lack
access to a huge grain market in Asia.
Dwarf bunt is caused by the fungus, Tilletia controversa Kuhn (TCK). Spores require cold
temperatures for long periods of time, high moisture, and light to reproduce. In wheat fields, these
requirements are provided by a prolonged snow cover through the winter and spring, a common
condition in Utah's Cache Valley. In late winter, the germinating fungus infects wheat seedlings and
develops slowly as the wheat plants grow. When the infected plants mature, it grows rapidly, invades
the kernels, and destroys wheat kernels. TCK-infected wheat heads are black, soft, and possess a
very unpleasant odor. (The disease is often called dwarf "smut").
Dr. Adetuyi and I realized that our P. syringae pv. syringae strain M 1 was obtained from a wheat
field infested with the TCK fungus. We discarded blackened kernels in search of healthy kernels to
isolate our bacteria. Strain Ml, the strong syringomycin-E producer, was isolated from kernels of
healthy plants among diseased plants. Did strain M 1 afford protection against the fungus? And, "vas
strain Ml 's ability to protect conferred by syringomycin-E? These are questions that we are now
examining in an effort to determine whether strain M 1 and its syringomycin may be used in
biocontrol of dwarf bunt.
The experiments are underway. In the laboratory, syringomycin-E and strain Ml do inhibit
the fungus as it germinates from spores. Wheat plants and seeds infected with TCK have been
challenged with syringomycin and the bacterium, and their effectiveness will be assessed when the
plants reach maturity. TCK spore germination in the cold requires 6 to 8 weeks, and the plant experiments will require months. As molecular biologists working with organisms like yeast, we usually
conduct experiments that can be completed in a day or overnight. We will need to _adjust to the
longer experiments of plant pathologists.

MEDICAL ApPLICATIONS
Even though P. syringae pv. syringae is a plant bacterium, perhaps the syringomycins could be
used to inhibit fungi of medical importance. We briefly looked at the ability of syringomycin-E to kill
some well-known fungal human pathogens. As we anticipated, it was indeed effective (Table 1).

TABLE I. Growth Inhibitory Activity of Syringomycin-E
Against Human Pathogenic Fungi
MIC (uglmli

FUNGUS TESTED
Aspergillus Jumigatus

25

Candida a/means

6.25

Candida kefyr

3.12

Cryptococcus neoJormans

1.56

Saccharomyces cerevisiae

2

1.56

lMinimal inhibitory concentration
zNon-pathogenic
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Cryptococcus neofonnans, a yeast-type fungus, was as sensitive to syringomycin-E as our model organism, S. cerevisiae. This caught our eye because we knew that C. neofonnans had recently attracted
much attention in the medical community.

C. neofonnans is prevalent in bird feces, especially of pigeons, but it also a major human pathogen in opportunistic infectious diseases of immunocompromised individuals (Williams, 1991), such as
Acquired Immunodeficiency Syndrome (AIDS). An estimated 20% of individuals with AIDS eventually succumb to C. neofonnans. Infections begin in the lungs, invade the nervous tissues and the
brain, giving rise to a condition known as cryptococcal meningitis. Susceptibility exists whenever the
immune system is suppressed-a situation that happens with the infirm and elderly as well as those
with certain cancers, including inherited ones.
The prospect that the syringomycins inhibit human pathogenic yeasts such as C. neofonnans
could be important in medicine. Of course, many questions remain about the effectiveness of the
syringomycins in treating human disease. All therapies must be employed against AIDS, and we feel
that we have a social responsibility to see if the syringomycins could help in this endeavor.

SUMMARY
Our views of the role of the syringomycins have changed more than once over the last few
years. They were initially considered to be major plant virulence factors, then iron chelators, and now
they appear to be antifungal agents. The syringomycin story is an example of how science should
work. Scientific hypotheses are constantly made and challenged, and then abandoned, altered, or
retained. The force behind the process is the continual accumulation of knowledge generated by
research. My colleagues and I will continue to study the syringomycins. We think we are close to
finding their role in nature, but as we have seen, the search may take us in unexpected directions.
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